Refractive surgery contraindications, FDA news lead March coverage
Click Here to Manage Email Alerts
Contraindications for refractive surgery and FDA news led Healio/OSN’s coverage in the beginning of March.
Read the recent top-performing ophthalmology articles below.
Study finds pregnancy a contraindication for refractive surgery
A study investigating the outcomes of LASIK and PRK in women who underwent refractive surgery while unaware of their pregnancy found significantly worse results compared with those who were not pregnant. Read more.
FDA accepts NDA for dry eye nasal spray
The FDA has accepted a new drug application from Oyster Point Pharma for OC-01, a nasal spray treatment for the signs and symptoms of dry eye disease. Read more.
Optimal dose, concentration of moxifloxacin needed to prevent endophthalmitis
Endophthalmitis cases in a large retrospective clinical cohort study of patients who underwent cataract surgery were related to organism resistance in cefuroxime-treated eyes and sensitive organisms in moxifloxacin-treated eyes. Read more.
Omni receives FDA clearance for additional indication
The FDA has granted 510(k) clearance to the Omni surgical system for canaloplasty followed by trabeculotomy to reduce IOP in primary open-angle glaucoma, according to a press release from Sight Sciences. Read more.
FDA accepts IND for presbyopia drop
The FDA has accepted an investigational new drug application for Brimochol, according to a press release from Visus Therapeutics. Read more.
Collapse
Healio Coverage
Click Here to Manage Email Alerts